Pilot study probes safe exercise limits for rare heart condition

NCT ID NCT06823271

Completed Knowledge-focused Sponsor: Technical University of Munich Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This completed pilot study looked at how moderate exercise affects heart function and dangerous heart rhythms in 20 adults with arrhythmogenic cardiomyopathy (ACM). Participants did different types of exercise while doctors measured heart pressures and electrical activity. The goal is to understand which types of exercise might be safer for people with ACM.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this study could help doctors give safer exercise advice to people with arrhythmogenic cardiomyopathy.
What could go wrong: This is a very small pilot study (20 people) that only measures short-term effects. It cannot prove long-term safety or benefit.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ARRHYTHMIAS, CARDIAC are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Arrhythmias, Cardiac arrhythmogenic right ventricular cardiomyopathy cardiac rhythm disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ARRHYTHMIAS, CARDIAC

Contacts and locations

Locations

Technische Universität München

München, 81675, Germany

More trials for these conditions

Other studies related to the condition(s) this trial covers.